NASDAQ · Healthcare · Biotechnology
Zentalis Pharmaceuticals, Inc.
ZNTL
Zentalis Pharmaceuticals, Inc. CEO Julia Marie Eastland · Market cap $272.3M.
$3.83
-0.01 · -0.39%
52w hi $6.9552w lo $1.21
Off 52w high 45.0%
75
STRONG
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
2 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $8.33
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 14 | WALTERS GROUP | Buy | 4,335,000 | $3.50 | +$15.17M | 75 | |
| Dec 31 | WALTERS GROUP | Buy | 6,459,973 | $1.20 | +$7.75M | 76 | |
| Dec 15 | Matrix Capital Management Company, LP | Sell | 7,500,000 | $1.33 | −$9.97M | 56 | |
| Apr 30 | Scott Dunseth Myers | Buy | 21,000 | $1.40 | +$29K | 34 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug